Medtronic, a global leader in healthcare technology, is proud to announce that it has been honored with the 2025 MedTech Breakthrough Award for 'Best Overall Medical Device Solution' for its HealthCast™ intelligent patient monitoring solution. This award recognizes the company’s commitment to empowering clinicians to provide exceptional patient care through groundbreaking technology and insights..

全球医疗技术领导者美敦力公司自豪地宣布，其HealthCast™智能患者监测解决方案荣获2025年MedTech突破奖“最佳整体医疗器械解决方案”。该奖项表彰了该公司通过开创性技术和洞察力助力临床医生提供卓越患者护理的承诺。

MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. This year, the HealthCast™ intelligent patient monitoring solution from Medtronic stood out for its approach to advancing the status quo of patient monitoring and simplifying patient management.

MedTech Breakthrough 是一家独立的市场情报组织，致力于表彰全球健康和医疗技术市场中的顶尖公司、技术和产品。今年，美敦力的 HealthCast™ 智能患者监测解决方案因其在推动患者监测现状改进和简化患者管理方面的创新方法而脱颖而出。

1,2

1,2

.

。

An offering of the Acute Care & Monitoring business of Medtronic, HealthCast™ intelligent patient monitoring is a portfolio of connectivity, interoperability, and remote monitoring solutions. By addressing the limitations of intermittent spot checks, HealthCast™ aims to provide continuous monitoring that may help in the early detection of physiologic decline.

HealthCast™ 智能患者监护系统是美敦力急性护理与监测业务的一项产品，该产品组合涵盖连接性、互操作性和远程监护解决方案。通过解决间歇性抽查的局限性，HealthCast™ 致力于提供可能有助于早期发现生理恶化的持续监护。

3

3

, potentially aiding in the reduction of unplanned ICU admissions and supporting improved patient outcomes

，可能有助于减少非计划的重症监护室（ICU）入院，并支持改善患者预后

4

4

. The use of continuous multi-parameter monitoring has been associated with positive clinical outcomes, such as decreased mortality

连续多参数监测的使用与积极的临床结果相关，例如死亡率降低。

5

5

and reduced hospital length of stay

并且缩短了住院时间

6

6

. The HealthCast™ portfolio supports healthcare professionals with the tools necessary to make informed clinical decisions, enhancing patient care from hospital to home

HealthCast™ 产品组合为医疗专业人员提供必要的工具，以做出明智的临床决策，从而加强从医院到家庭的患者护理。

7

7

.

。

The HealthCast™ portfolio includes:

HealthCast™ 产品组合包括：

HealthCast™ wearables

HealthCast™ 可穿戴设备

: Extend patient monitoring in hospital and home settings by empowering clinical teams to get ahead of patient decline with valuable insights and automated, personalized trending notifications to support proactive decision-making and support patient discharge decisions

：通过赋予临床团队有价值的洞察力和自动化、个性化的趋势通知，帮助他们在患者病情恶化前提前采取措施，从而扩展医院和家庭环境中的患者监测，支持积极的决策制定并协助患者出院决策。

8

8

.

。

Learn more about BioButton®* multi-parameter wearable.

了解有关 BioButton®* 多参数可穿戴设备的更多信息。

††

††

HealthCast™ remote monitoring

HealthCast™ 远程监控

: Remotely monitor patients providing continuous, near real-time data, insights, and alarms so staff can visualize patient data, respond quickly, and connect data with the EMR.

远程监控患者，提供持续的、近乎实时的数据、洞察和警报，使工作人员能够查看患者数据、快速响应并将数据连接到电子病历 (EMR)。

Learn more about Vital Sync™ remote patient monitoring.

了解有关Vital Sync™远程患者监护的更多信息。

HealthCast™ services

健康播报™ 服务

: Providing tailored support, including assistance for delivery, device EMR connectivity, technical training, connection service plans, and customer success.

：提供定制支持，包括交付协助、设备EMR连接、技术培训、连接服务计划以及客户成功支持。

Learn more about HealthCast™ services.

了解有关 HealthCast™ 服务的更多信息。

'We are incredibly honored to receive the MedTech Breakthrough Award for HealthCast™ intelligent patient monitoring,' said Jason Case, vice president research and development for the Acute Care & Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic. 'This recognition highlights our dedication to innovation and our commitment to empowering clinicians with technologies to enhance the quality of care for their patients.

“我们非常荣幸能够凭借HealthCast™智能患者监护系统获得MedTech突破奖，”美敦力外科医疗组合中急性护理与监测业务的研发副总裁贾森·凯斯表示，“这一认可彰显了我们对创新的专注以及我们致力于通过技术为临床医生赋能、提升患者护理质量的承诺。”

HealthCast™ intelligent patient monitoring reflects the Acute Care & Monitoring business's focus on empowering healthcare professionals with world-class technology to personalize patient care, anytime, anywhere.'.

HealthCast™ 智能患者监测反映了急性护理与监测业务专注于通过世界级技术赋能医疗专业人员，随时随地实现个性化患者护理。

As part of its mission, Medtronic is committed to reducing disparities in outcomes, expanding access, and helping to protect more patients in more places.

作为其使命的一部分，美敦力致力于减少结果差异、扩大获取渠道，并帮助在更多地方保护更多患者。

For more information about HealthCast™ intelligent patient monitoring and innovative solutions from Medtronic, please visit

如需了解更多关于美敦力的HealthCast™智能患者监测和创新解决方案的信息，请访问

Medtronic.com/HealthCast™.

美敦力公司/健康广播™。

About Medtronic

关于美敦力

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更有力的行动。我们是美敦力。美敦力公共有限公司，总部位于爱尔兰戈尔韦，是一家领先的全球医疗技术公司，通过寻找并发现解决方案，勇敢地应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长生命——将遍布150多个国家的95,000多名充满热情的员工团结在一起。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、外科机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们多样化的知识、永无止境的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

我们致力于推动以洞察力为导向的护理、以人为本的体验，以及为我们的世界带来更好的结果，因此请对我们有更多期待。在我们所做的一切中，我们正在创造非凡的工程。如需更多关于美敦力的信息，请访问。

www.Medtronic.com

www.美敦力.com

and follow Medtronic on

并关注美敦力

LinkedIn

领英

.

。

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

任何前瞻性陈述都受到风险和不确定性的影响，例如美敦力公司向证券交易委员会提交的定期报告中描述的那些。实际结果可能与预期结果有重大差异。

Patient monitoring products should not be used as the sole basis for diagnosis or therapy and are intended only as an adjunct in patient assessment.

患者监护产品不应作为诊断或治疗的唯一依据，仅用作患者评估的辅助工具。

®

®

* Third party brands are trademarks of their respective owners.

* 第三方品牌是其各自所有者的商标。

† The BioButton®* multi-parameter wearable device is not intended for critical care monitoring.

† BioButton®* 多参数可穿戴设备不适用于重症监护监测。

1. Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S. Experiences of current vital signs monitoring practices and views of wearable monitoring: A qualitative study in patients and nurses. Journal of advanced nursing. 2022 Mar;78(3):810-22.

1. Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S。当前生命体征监测实践的体验及对可穿戴监测的看法：患者与护士的定性研究。《高级护理杂志》。2022年3月；78(3):810-22。

2. Becking-Verhaar FL, Verweij RPH, de Vries M, Vermeulen H, van Goor H, Huisman-de Waal GJ. Continuous Vital Signs Monitoring with a Wireless Device on a General Ward: A Survey to Explore Nurses’ Experiences in a Post-Implementation Period. International Journal of Environmental Research and Public Health.

2. Becking-Verhaar FL, Verweij RPH, de Vries M, Vermeulen H, van Goor H, Huisman-de Waal GJ. 在普通病房使用无线设备进行持续生命体征监测：实施后阶段护士体验调查。《国际环境研究与公共卫生杂志》。

2023; 20(10):5794..

2023；20（10）：5794。。

3. Vroman H, Mosch D, Eijkenaar F, Naujokat E, Mohr B, Medic G, Swijnenburg M, Tesselaar E, Franken M. Continuous vital sign monitoring in patients after elective abdominal surgery: a retrospective study on clinical outcomes and costs. Journal of Comparative Effectiveness Research. 2023 Feb;12(2):e220176..

3. Vroman H, Mosch D, Eijkenaar F, Naujokat E, Mohr B, Medic G, Swijnenburg M, Tesselaar E, Franken M. 择期腹部手术后患者的连续生命体征监测：关于临床结果和成本的回顾性研究。《比较效果研究杂志》。2023年2月；12(2):e220176。

4. Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. Br J Anaesth. 2022 May;128(5):857-863.

4. Eddahchouri Y, Peelen RV, Koeneman M, Touw HRW, van Goor H, Bredie SJH。连续无线生命体征监测对计划外ICU入院和快速反应小组呼叫的影响：一项前后对比研究。《英国麻醉学杂志》。2022年5月；128（5）：857-863。

https://pubmed.bi.nlm.nih.gov/35282866/

https://pubmed.bi.nlm.nih.gov/35282866/

5. Sun L, Joshi M, Khan SN, Ashrafian H, Darzi A. Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis. Journal of the Royal Society of Medicine. 2020 Jun;113(6):217-24.

5. 孙L，乔希M，汗SN，阿什拉菲安H，达齐A。多参数连续无创监测在医院病房的临床影响：一项系统评价和荟萃分析。《皇家医学会杂志》。2020年6月；113（6）：217-24。

6. Brown H, Terrence J, Vasquez P, Bates DW, Zimlichman E. Continuous monitoring in an inpatient medical-surgical unit: a controlled clinical trial. Am J Med. 2014;127(3):226-32.

6. 布朗 H，特伦斯 J，巴斯克斯 P，贝茨 DW，齐姆利希曼 E。住院内科外科病房的持续监测：一项对照临床试验。《美国医学杂志》。2014；127（3）：226-32。

7. Breteler MJM, Numan L, Ruurda JP, van Hillegersberg R, van der Horst S, Dohmen DAJ, van Rossum MC, Kalkman CJ. Wireless Remote Home Monitoring of Vital Signs in Patients Discharged Early After Esophagectomy: Observational Feasibility Study. JMIR Perioper Med. 2020 Dec 4;3(2):e21705

7. Breteler MJM、Numan L、Ruurda JP、van Hillegersberg R、van der Horst S、Dohmen DAJ、van Rossum MC、Kalkman CJ。食管切除术后早期出院患者生命体征的无线远程家庭监测：观察性可行性研究。JMIR 围手术期医学。2020年12月4日；3（2）：e21705。

8. Weller RS, Foard KL, Harwood TN. Evaluation of a wireless, portable, wearable multi-parameter vital signs monitor in hospitalized neurological and neurosurgical patients.

8. Weller RS, Foard KL, Harwood TN。评估无线、便携、可穿戴的多参数生命体征监测仪在住院的神经科和神经外科患者中的应用。

J Clin Monit Comput

临床监测与计算杂志

. 2018;32(5):945–951.

. 2018;32(5):945–951.

Contacts

联系人

Pamela Lee

潘蜜拉·李

Public Relations

公共关系

+1-303-218-8264

+1-303-218-8264

Ryan Weispfenning

瑞安·魏斯芬宁

Investor Relations

投资者关系

+1-763-505-4626

+1-763-505-4626